US Stock MarketDetailed Quotes

YMAB Y-mAbs Therapeutics

Watchlist

4.960
-0.230-4.43%

Close Mar 4 16:00 ET

4.960
0.0000.00%

Post 20:01 ET

224.28MMarket Cap-7.40P/E (TTM)

Y-mAbs Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Y-mAbs Therapeutics Q4 2024 Earnings Date

Currency：USDMar 4, 2025

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	26.70M	26.50M	-206.38K
Miss Est.	+14.29%	+13.41%	-0.77%
EPS	-0.12	-0.15	-0.03
Miss Est.	-485.93%	-650.00%	-28.64%

Analyst Rating

Strong Buy

Mar 4, 2025

Y-mAbs Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q2	-- / 23.310M	--
--	2025/Q1	-- / 22.564M	--
Mar 4, 2025	2024/Q4	26.495M / 26.701M	--
Nov 8, 2024	2024/Q3	18.461M / 23.263M	--
Aug 12, 2024	2024/Q2	22.798M / 23.019M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q2-- / 23.310M--

--2025/Q1-- / 22.564M--

Mar 4, 20252024/Q426.495M / 26.701M--

Nov 8, 20242024/Q318.461M / 23.263M--

Aug 12, 20242024/Q222.798M / 23.019M--

Unlock Free Earnings Estimates

Open Account

Y-mAbs Therapeutics Earnings Reports

Y-mAbs Therapeutics | 10-K: FY2024 Annual Report

Mar 4 07:25 ET

Y-mAbs Therapeutics | 8-K: Y-mAbs Reports Fourth Quarter 2024 Financial Results and Recent Corporate Developments

Mar 4 07:15 ET

Y-mAbs Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 8, 2024 07:20 ET

Y-mAbs Therapeutics | 8-K: Y-mAbs Reports Third Quarter 2024 Financial Results and Recent Corporate Developments

Nov 8, 2024 06:59 ET